Amy E. Parker
Impact in
- Ophthalmology top 5%
- Glaucoma and retinal disorders
- Genetics top 10%
- Virus-based gene therapy research
Papers in
-
- CRISPR and Genetic Engineering 2
- Fibroblast Growth Factor Research 2
- Viral Infectious Diseases and Gene Expression in Insects 1
- Glycosylation and Glycoproteins Research 1
- Genetics 5
- Virus-based gene therapy research 4
- Co-authors
- M. Rosario Hernandez (3 shared papers)Shuanglin Xiang (1 shared paper)Johannes Fruehauf (1 shared paper)Laura Borodyansky (1 shared paper)Paula E. Pecen (2 shared papers)Mercedes Salvador‐Silva (2 shared papers)Haixi Miao (1 shared paper)Jon W. Gordon (1 shared paper)
- Journals
- Blood (2 papers)Glia (2 papers)Human Gene Therapy (1 paper)Physiological Genomics (1 paper)Cell Cycle (1 paper)
- Partner nations
- United StatesGermanyCanada
In The Last Decade
Amy E. Parker
11 papers receiving 475 citations
Peers
Comparison fields: 5 of 57
- Ophthalmology 77
- Genetics 185
- Hematology 60
- Molecular Biology 312
- Oncology 85
Countries citing papers authored by Amy E. Parker
This map shows the geographic impact of Amy E. Parker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy E. Parker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy E. Parker more than expected).
Fields of papers citing papers by Amy E. Parker
This network shows the impact of papers produced by Amy E. Parker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy E. Parker. The network helps show where Amy E. Parker may publish in the future.
Co-authors
The 25 scholars most cited alongside Amy E. Parker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 149 | |
| 2 | 2003 | 85 | |
| 3 | 2004 | 60 | |
| 4 | 2003 | 57 | |
| 5 | 2007 | 53 | |
| 6 | 2003 | 46 | |
| 7 | 2004 | 30 | |
| 8 | 2005 | 11 | |
| 9 | 2000 | 10 | |
| 10 | 2001 | 3 | |
| 11 | 1999 | 2 |
About Amy E. Parker
Amy E. Parker is a scholar working on Molecular Biology, Genetics, Infectious Diseases, Oncology and Epidemiology, having authored 11 papers that have together received 506 indexed citations. Recurring topics across this work include Virus-based gene therapy research (4 papers), CRISPR and Genetic Engineering (2 papers), Tuberculosis Research and Epidemiology (2 papers), Mycobacterium research and diagnosis (2 papers), CAR-T cell therapy research (2 papers), Fibroblast Growth Factor Research (2 papers), Viral Infectious Diseases and Gene Expression in Insects (1 paper) and Glycosylation and Glycoproteins Research (1 paper). The work is most often cited by research in Ophthalmology (77 citations), Genetics (185 citations), Hematology (60 citations), Molecular Biology (312 citations) and Oncology (85 citations). Amy E. Parker has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include M. Rosario Hernandez, Shuanglin Xiang, Johannes Fruehauf, Laura Borodyansky, Paula E. Pecen, Mercedes Salvador‐Silva, Haixi Miao, Jon W. Gordon, J. Fraser Wright and Alan McClelland. Their work appears in journals such as Blood, Glia, Human Gene Therapy, Physiological Genomics and Cell Cycle.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.